
Clinical trials in oncology demand standardized measurements of imaging scans to assess treatment response, but, unfortunately, the existing clinical workflow is not designed to produce these cohesive measurements on a routine basis. A group from Dana Farber Cancer Center has proposed using imaging analysts to deliver more consistent results.

























